mRNA vaccines — a new era in vaccinology

Cited by (1,011)

Items 301–400 of 1,011

  1. mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
    Zhuang, Xinyu, Qi, Yanxin, Wang, Maopeng, Yu, Ning, Nan, Fulong, Zhang, He, Tian, Mingyao, Li, Chang, Lu, Huijun, Jin, Ningyi · 2020 · Vaccines
  2. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
    Ger T. Rijkers, Nynke Weterings, Andrés Obregón‐Henao, Tara Dutt, Taru S. Dutt, Frans J. van Overveld, Marcela I. Henao-Tamayo · 2021 · Vaccines
  3. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
    Hongbo Wang, Qinghai Meng, Jinjun Qian, Muxi Li, Chunyan Gu, Ye Yang · 2022 · Pharmacology & Therapeutics
  4. Vaccine-like nanomedicine for cancer immunotherapy
    Yunfei Yi, Mian Yu, Wen Li, Dunwan Zhu, Lin Mei, Meitong Ou · 2023 · Journal of Controlled Release
  5. Towards superior dendritic-cell vaccines for cancer therapy
    Mansi Saxena, Sreekumar Balan, Vladimir Roudko, Nina Bhardwaj · 2018 · Nature Biomedical Engineering
  6. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
    Kai K. Ewert, Pablo Scodeller, Lorena Simón‐Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu, Cyrus R. Safinya · 2021 · Pharmaceutics
  7. Aptamer-Based Targeted Delivery of Functional Nucleic Acids
    Sitao Xie, Weidi Sun, Ting Fu, Xiangsheng Liu, Peng Chen, Liping Qiu, Fengli Qu, Weihong Tan · 2023 · Journal of the American Chemical Society
  8. Game changers in science and technology - now and beyond
    Ulrich A. K. Betz, Loukik Arora, R.A. Assal, Hatylas F. Z de Azevedo, Jeremy Baldwin, Michael S. Becker, Stefan Bostock, Vinton W.T. Cheng, Tobias Egle, Nicola Ferrari et al. · 2023 · Technological Forecasting and Social Change
  9. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
    Yang, Ren, Deng, Yao, Huang, Baoying, Huang, Lei, Lin, Ang, Li, Yuhua, Wang, Wenling, Liu, Jingjing, Lu, Shuaiyao, Zhan, Zhenzhen et al. · 2021 · Signal Transduction and Targeted Therapy
  10. COVID-19 Vaccination in Pregnant and Lactating Women
    Emily H. Adhikari, Catherine Y. Spong · 2021 · JAMA
  11. Nanovaccine: an emerging strategy
    Amrita Das, Nahid Ali · 2021 · Expert Review of Vaccines
  12. mRNA nanomedicine: Design and recent applications
    Luke J. Kubiatowicz, Animesh Mohapatra, Nishta Krishnan, Ronnie H. Fang, Liangfang Zhang · 2022 · Exploration
  13. Lipid carriers for mRNA delivery
    Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen, Wei He · 2022 · Acta Pharmaceutica Sinica B
  14. Nanoplatforms for mRNA Therapeutics
    Meng, Chaoyang, Chen, Zhe, Li, Gang, Welte, Thomas, Shen, Haifa · 2021 · Advanced Therapeutics
  15. Therapeutic Vaccines for HPV-Associated Malignancies
    Claire Smalley Rumfield, Nicholas Roller, Samuel Troy Pellom, Jeffrey Schlom, Caroline Jochéms · 2020 · ImmunoTargets and Therapy
  16. Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo
    Elizabeth Voke, Mariah Lynn Arral, Henry John Squire, Teng-Jui Lin, Lining Zheng, Roxana Coreas, Alison Lui, Anthony T. Iavarone, Rebecca L. Pinals, Kathryn A. Whitehead et al. · 2025 · Nature Communications
  17. mRNA Delivery by a pH‐Responsive DNA Nano‐Hydrogel
    Xin Fu, Tianshu Chen, Yuchen Song, Chang Feng, Huinan Chen, Qianqian Zhang, Guifang Chen, Xiaoli Zhu · 2021 · Small
  18. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery
    Grayson Tilstra, Julien Couture‐Senécal, Yan Ming Anson Lau, Alanna M. Manning, D. Wong, Wanda W. Janaeska, Titobioluwa A. Wuraola, Janice Pang, Omar F. Khan · 2023 · Journal of the American Chemical Society
  19. Polysaccharides of mushroom Pleurotus spp.: New extraction techniques, biological activities and development of new technologies
    Jhonatas Rodrigues Barbosa, Maurício Madson dos Santos Freitas, Luiza Helena da Silva Martins, Raul Nunes de Carvalho · 2019 · Carbohydrate Polymers
  20. Nanoparticle formulated vaccines: opportunities and challenges
    Pingsai Lung, Jingnan Yang, Quan Li · 2020 · Nanoscale
  21. Biomedical applications of mRNA nanomedicine
    Xiong, Qingqing, Lee, Gha Young, Ding, Jianxun, Li, Wenliang, Shi, Jinjun · 2018 · Nano Research
  22. Current Status of Zika Virus Vaccines: Successes and Challenges
    Aryamav Pattnaik, Bikash Ranjan Sahoo, Asit K. Pattnaik · 2020 · Vaccines
  23. Quality by Design for enabling RNA platform production processes
    Simon Daniel, Zoltán Kis, Cleo Kontoravdi, Nilay Shah · 2022 · Trends in biotechnology
  24. Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols
    Stefano Giordani, Valentina Marassi, Andrea Zattoni, Barbara Roda, Pierluigi Reschiglian · 2023 · Journal of Pharmaceutical and Biomedical Analysis
  25. Circular RNA: A promising new star of vaccine
    Jindong Xie, Fengxi Ye, Xinpei Deng, Yuhui Tang, Jie‐Ying Liang, Xufeng Huang, Yuying Sun, Hailin Tang, Jinsong Lei, Shaoquan Zheng et al. · 2023 · Journal of Translational Internal Medicine
  26. Self-degradable lipid-like materials based on “hydrolysis accelerated by the intra-particle enrichment of reactant (HyPER)” for messenger RNA delivery
    Tanaka, Hiroki, Takahashi, Tatsunari, Konishi, Manami, Takata, Nae, Gomi, Masaki, Shirane, Daiki, Miyama, Ryo, Hagiwara, Shinya, Yamasaki, Yuki, Sakurai, Yu et al. · 2020 · Advanced Functional Materials
  27. Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery
    Lokugamage, Melissa P., Gan, Zubao, Zurla, Chiara, Levin, Joel, Islam, Fatima Z., Kalathoor, Sujay, Sato, Manaka, Sago, Cory D., Santangelo, Philip J., Dahlman, James E. · 2020 · Advanced Materials
  28. The solid progress of nanomedicine
    João Pedro Martins, José das Neves, María de la Fuente, Christian Celia, Helena F. Florindo, Nazende Günday-Türeli, Amirali Popat, José Luis Santos, Flávia Sousa, Ruth Schmid et al. · 2020 · Drug Delivery and Translational Research
  29. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
    Joyce K. Hwang, Tian Zhang, Andrew Zhuang Wang, Zihai Li · 2021 · Journal of Hematology & Oncology
  30. Development and Delivery Systems of mRNA Vaccines
    Yongjun Liang, Liping Huang, Tiancai Liu · 2021 · Frontiers in Bioengineering and Biotechnology
  31. COVID-19 vaccination in kidney transplant recipients
    Sophie Caillard, Olivier Thaunat · 2021 · Nature Reviews Nephrology
  32. Emerging vaccine nanotechnology: From defense against infection to sniping cancer
    Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, Dylan Neal Patel, Jiang Ouyang, Zhongmin Tang, Na Kong, Enguo Chen, Wei Tao · 2022 · Acta Pharmaceutica Sinica B
  33. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
    Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, Sarah Christina Sasson · 2023 · Frontiers in Immunology
  34. Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer
    Shiyan Dong, Xuan Liu, Ye Bi, Yifan Wang, Abin Antony, DaeYong Lee, Kristin Michelle Huntoon, Seong Dong Jeong, Yifan Ma, Xuefeng Li et al. · 2023 · Nature Communications
  35. Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection
    Roy Pattipeiluhu, Ye Zeng, Marco M. R. M. Hendrix, Ilja Karina Voets, Alexander Kros, Thomas Harry Sharp · 2024 · Nature Communications
  36. The nano delivery systems and applications of mRNA
    Mingyuan Li, Yuan Li, Shiqin Li, Lin Jia, Haomeng Wang, Meng Li, Jie Deng, Ali Zhu, Liqiao Ma, Weihong Li et al. · 2021 · European Journal of Medicinal Chemistry
  37. Targeting TFH cells in human diseases and vaccination: rationale and practice
    Di Yu, Lucy S. K. Walker, Zheng Liu, Michelle A. Linterman, Zhanguo Li · 2022 · Nature Immunology
  38. Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
    Xin Bai, Qijing Chen, Fengqiao Li, Yilong Teng, Maoping Tang, Jia Huang, Xiaoyang Xu, Xue‐Qing Zhang · 2024 · Nature Communications
  39. Novel approaches for the design, delivery and administration of vaccine technologies
    Wallis, J, Shenton, D P, Carlisle, R C · 2019 · Clinical and Experimental Immunology
  40. Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
    Edo Kon, Itai Benhar · 2019 · Drug Resistance Updates
  41. mRNA-Based Vaccines
    Frank Kowalzik, Daniel Schreiner, Christian Jensen, Daniel Teschner, Stephan Gehring, Fred Zepp · 2021 · Vaccines
  42. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
    Zhuoya Deng, Yuying Tian, Jianxun Song, Guangwen An, Penghui Yang · 2022 · Frontiers in Immunology
  43. RNA therapeutics: updates and future potential
    Caroline Zhang, Biliang Zhang · 2022 · Science China Life Sciences
  44. Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA
    Weiwen Kong, Yuning Wei, Zirong Dong, Wenjuan Liu, Jiaxin Zhao, Yan Huang, Jinlong Yang, Wei Wu, Haisheng He, Jianping Qi · 2024 · Journal of Nanobiotechnology
  45. SARS-CoV-2 vaccines: Lights and shadows
    Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, Dina Visca, Paolo Verdecchia · 2021 · European Journal of Internal Medicine
  46. Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports
    Konstantinos Katsikas Triantafyllidis, Panagiotis Giannos, Imran Tariq-Mian, George Kyrtsonis, Konstantinos S. Kechagias · 2021 · Vaccines
  47. Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
    Bolin Wang, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu · 2023 · Frontiers in Immunology
  48. Clinical advances of mRNA vaccines for cancer immunotherapy
    Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, Yan Tang, Wei Tao · 2025 · Med
  49. Vaccination strategies to combat novel corona virus SARS-CoV-2
    Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti, Mukesh Samant · 2020 · Life Sciences
  50. Next-Generation TB Vaccines: Progress, Challenges, and Prospects
    Zhuang Li, Zhaoyang Ye, Linsheng Li, Ling Yang, Wenping Gong · 2023 · Vaccines
  51. RNA Modifications Modulate Activation of Innate Toll-Like Receptors
    Isabel Freund, Tatjana Eigenbrod, Mark Helm, Alexander H. Dalpke · 2019 · Genes
  52. Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
    Sita Awasthi, Lauren M. Hook, Norbert Pardi, Fushan Wang, Arpita Myles, Michael P. Cancro, Gary H. Cohen, Drew Weissman, Harvey M. Friedman · 2019 · Science Immunology
  53. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
    Rudra P. Saha, Ashish Ranjan Sharma, Manoj Kumar Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang Soo Lee, Chiranjib Chakraborty · 2020 · Frontiers in Pharmacology
  54. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
    Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao · 2023 · Cells
  55. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery
    Lulu Xue, Gan Zhao, Ningqiang Gong, Xuexiang Han, Sarah J. Shepherd, Xinhong Xiong, Zebin Xiao, Rohan Palanki, Junchao Xu, Kelsey L. Swingle et al. · 2024 · Nature Nanotechnology
  56. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
    Nakamura, Takashi, Sato, Yusuke, Yamada, Yuma, Abd Elwakil, Mahmoud M., Kimura, Seigo, Younis, Mahmoud A., Harashima, Hideyoshi · 2022 · Advanced Drug Delivery Reviews
  57. COVID‐19 vaccine research and development: ethical issues
    Tri Wibawa · 2020 · Tropical Medicine & International Health
  58. New viral vectors for infectious diseases and cancer
    Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, Elisa Scarselli, Antonella Folgori, Alfredo Nicosia · 2020 · Seminars in Immunology
  59. Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism
    Albert L. Hsu, Traci Johnson, Lynelle M. Phillips, Taylor Nelson · 2021 · Open Forum Infectious Diseases
  60. Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis
    Ivan T. Lee, Raffael Nachbagauer, David J. Ensz, Howard Schwartz, Lizbeth Carmona, Kristi Schaefers, Andrei S. Avanesov, Daniel Stadlbauer, Carole Henry, Ren Chen et al. · 2023 · Nature Communications
  61. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence
    Sarah Wack, Timothy Patton, Laura Korb Ferris · 2021 · Journal of the American Academy of Dermatology
  62. Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
    Dapeng Zhang, Elena N. Atochina‐Vasserman, Devendra S. Maurya, Matthew Liu, Qi Xiao, Juncheng Lu, George Lauri, Nathan A. Ona, Erin K. Reagan, Houping Ni et al. · 2021 · Journal of the American Chemical Society
  63. Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals
    Marie I. Samanovic, Amber R. Cornelius, Sophie L. Gray-Gaillard, Joseph R. Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Hyman, Michael Tuen, Sergei B. Koralov, Mark J. Mulligan et al. · 2022 · Science Translational Medicine
  64. Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids
    Gyan Prakash, Ahmed Shokr, Niels G. A. Willemen, Showkeen Muzamil Bashir, Su Ryon Shin, Shabir Hassan · 2022 · Advanced Drug Delivery Reviews
  65. Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions.
    Stefan Pfattheicher, Michael Bang Petersen, ROBERT M. BOHM · 2021 · Health Psychology
  66. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
    Mattia Tiboni, Luca Casettari, Lisbeth Illum · 2021 · International Journal of Pharmaceutics
  67. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
    Clio Bilotta, Giulio Perrone, Valeria Adelfio, Giovanni Francesco Spatola, Maria Laura Uzzo, Antonina Argo, Stefania Zerbo · 2021 · Frontiers in Immunology
  68. From structural design to delivery: mRNA therapeutics for cancer immunotherapy
    Feng Zhou, Lujia Huang, Shiqin Li, Wenfang Yang, Fangmin Chen, Zhixiong Cai, Xiaolong Liu, Wujun Xu, Vesa‐Pekka Lehto, Ulrich Lächelt et al. · 2023 · Exploration
  69. Zika virus vaccines
    Peter Abbink, Kathryn E. Stephenson, Dan H. Barouch · 2018 · Nature Reviews Microbiology
  70. Current RNA-based Therapeutics in Clinical Trials
    Lingyan Zhou, Zhou Qin, Yanghui Zhu, Zhiyao He, Ting Xu · 2019 · Current Gene Therapy
  71. Development of mRNA Vaccines: Scientific and Regulatory Issues
    Knezevic, Ivana, Liu, Margaret A., Peden, Keith, Zhou, Tiequn, Kang, Hye-Na · 2021 · Vaccines
  72. Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
    Michael Lim, Abu Zayed Md Badruddoza, Jannatul Firdous, Mohammad A. Azad, Adnan Mannan, Taslim Ahmed Al-Hilal, Chong‐Su Cho, Mohammad Ariful Islam · 2020 · Pharmaceutics
  73. Advanced biomaterials for cancer immunotherapy
    Fan Yang, Kun Yu Shi, Yanpeng Jia, Ying Hao, Jinrong Peng, Zhiyong Qian · 2020 · Acta Pharmacologica Sinica
  74. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management
    Lacey McIntosh, Alexander A. Bankier, Gopal R. Vijayaraghavan, Robert Licho, Max Paul Rosen · 2021 · American Journal of Roentgenology
  75. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
    Guangna Liu, Motao Zhu, Xiao Zhao, Guangjun Nie · 2021 · Advanced Drug Delivery Reviews
  76. Machine Learning for Designing Next-Generation mRNA Therapeutics
    Sebastian M. Castillo-Hair, Georg Seelig · 2021 · Accounts of Chemical Research
  77. In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
    Yuxin Guo, Shao-Zhe Wang, Xinping Zhang, Hao‐Ran Jia, Ya‐Xuan Zhu, Xiaodong Zhang, Ge Gao, Yao‐Wen Jiang, Chengcheng Li, Xiaokai Chen et al. · 2022 · Nature Communications
  78. COVID-19: Therapeutics and Their Toxicities
    Michael A. Chary, Alexander F. Barbuto, Sudeh Izadmehr, Bryan D. Hayes, Michele M. Burns · 2020 · Journal of Medical Toxicology
  79. mRNA vaccines for COVID-19 and diverse diseases
    Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Faisal Irfan, Huining He, Jin Keun Chang, Xing‐Jie Liang, Yuhua Weng et al. · 2022 · Journal of Controlled Release
  80. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
    Mariona Estapé Sentí, Lucía García del Valle, Raymond Michel Schiffelers · 2024 · Advanced Drug Delivery Reviews
  81. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
    Javier Tadeo Granados-Riveron, Guillermo Aquino‐Jarquín · 2021 · Biomedicine & Pharmacotherapy
  82. Regulating trained immunity with nanomedicine
    Mandy M. T. van Leent, Bram Priem, David P. Schrijver, Anne de Dreu, Stijn R. J. Hofstraat, Robby C. Zwolsman, Thijs J. Beldman, Mihai Gheorghe Netea, Willem J. M. Mulder · 2022 · Nature Reviews Materials
  83. Making innate sense of mRNA vaccine adjuvanticity
    Kouji Kobiyama, Ken J. Ishii · 2022 · Nature Immunology
  84. Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues
    Nisha Chander, Genc Basha, Miffy H. Y. Cheng, Dominik Witzigmann, Pieter R. Cullis · 2023 · Molecular Therapy — Methods & Clinical Development
  85. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity
    Yining Zhu, Jingyao Ma, Ruochen Shen, Jinghan Lin, Shuyi Li, Xiaoya Lu, Jessica L. Stelzel, Jiayuan Kong, Leonardo Cheng, Ivan Vuong et al. · 2023 · Nature Biomedical Engineering
  86. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge
    Yongxiang Zhao, Baochao Fan, Xu Song, Jie Gao, Rongli Guo, Yi Cheng, Zhaoming He, Hongpeng Hu, Jianhao Jiang, Lixiang Zhao et al. · 2024 · mBio
  87. mRNA-encoded, constitutively active STINGV155M is a potent genetic adjuvant of antigen-specific CD8+ T cell response
    Sze‐Wah Tse, Kristine M. McKinney, William Walker, Mychael Nguyen, Jared Iacovelli, Clayton G. Small, Kristen Hopson, Tal Z. Zaks, Eric Huang · 2021 · Molecular Therapy
  88. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
    Cielo García Montero, Oscar Fraile‐Μartinez, Coral Bravo, Diego Torres‐Carranza, Lara Sánchez‐Trujillo, Ana Maria Gomez-Lahoz, Luis G. Guijarro, Natalio García‐Honduvilla, Ángel Asúnsolo, Julia Buján et al. · 2021 · Vaccines
  89. The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
    Dapeng Zhang, Elena N. Atochina‐Vasserman, Juncheng Lu, Devendra S. Maurya, Qi Xiao, Matthew Liu, Jasper Adamson, Nathan A. Ona, Erin K. Reagan, Houping Ni et al. · 2022 · Journal of the American Chemical Society
  90. Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
    Vlatkovic, Irena · 2021 · Biomedicines
  91. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
  92. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections
    Alex Abramson, Ameya R. Kirtane, Yunhua Shi, Grace Zhong, Joy E. Collins, Siddartha M. Tamang, Keiko Ishida, Alison M. Hayward, Jacob Wainer, Netra Unni Rajesh et al. · 2022 · Matter
  93. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
    Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang‐Soo Lee · 2021 · Frontiers in Immunology
  94. A Review of Pseudorabies Virus Variants: Genomics, Vaccination, Transmission, and Zoonotic Potential
    Zongyi Bo, Xiangdong Li · 2022 · Viruses
  95. A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
    Elizabeth K. Duperret, Alfredo Perales‐Puchalt, Regina Stoltz, Hiranjith G.H., Nitin Mandloi, James Barlow, Amitabha Chaudhuri, Niranjan Y. Sardesai, David B. Weiner · 2019 · Cancer Immunology Research
  96. Nanoparticle cancer vaccines: Design considerations and recent advances
    Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao, Guihua Huang · 2019 · Asian Journal of Pharmaceutical Sciences
  97. Advances in mRNA non-viral delivery approaches
    Maria Luigia Ibba, Giuseppe Ciccone, Carla Lucia Esposito, Silvia Catuogno, Paloma H. Giangrande · 2021 · Advanced Drug Delivery Reviews
  98. In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
    Zhongfeng Ye, Jinjin Chen, Xuewei Zhao, Yamin Li, Joseph Harmon, Changfeng Huang, Jianzhu Chen, Qiaobing Xu · 2022 · ACS Biomaterials Science & Engineering
  99. An overview of rational design of mRNA-based therapeutics and vaccines
    To, Kenneth K.W., Cho, William C.S. · 2021 · Expert Opinion on Drug Discovery
  100. Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis
    Mingzhu Gao, Maoping Tang, William Ho, Yilong Teng, Qijing Chen, Lei Bu, Xiaoyang Xu, Xue‐Qing Zhang · 2023 · ACS Nano